Insulin resistance is a hallmark of obesity and T2DM, disrupting normal insulin function
[DOI] [PubMed] [Google Scholar] 123.Elbadawy NN, et al
The American Diabetes Association (ADA) recognizes the cardiovascular benefits of GLP-1 receptor agonists in their Standards of Care but does not currently recommend these agents solely for inflammation management outside established indications for diabetes, obesity, or cardiovascular risk reduction
OEM Service Available: Accepts OEM orders with custom requirements and samples provided ASAP
GLP-1 stands for Glucagon-Like Peptide-1 , a hormone your body naturally produces in the gut
The oral form may be a particularly good fit if: You're newly diagnosed with type 2 diabetes and want to avoid injections You have prediabetes and are trying to prevent progression to T2D You've had an aversion to injections that has delayed starting treatment Your HbA1c and weight goals can be addressed together It may be less ideal if you already take multiple morning medications, travel frequently with disrupted routines, or have a condition affecting gastric motility